Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Becton Dickinson and Co (BDX) vs Herbalife Nutrition Ltd (HLF) Price & Performance

Becton Dickinson and CoTrade
Herbalife Nutrition LtdTrade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs Herbalife Nutrition Ltd — how do they compare? Becton Dickinson and Co trades at $180.77 (market cap $49.41B), while Herbalife Nutrition Ltd trades at $11.71 (market cap $1.23B). The key difference: Becton Dickinson and Co is far larger — about 40.2× Herbalife Nutrition Ltd's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.

BDXHLF
Market Cap
$49.41B$1.23B
Sector
HealthConsumer Staples
52-Week High
$185.39$19.96
52-Week Low
$138.62$7.75
Enterprise Value
$65.51B$3.06B
Dividend Yield
2.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Becton Dickinson and Co

BDX trades at $180.64, up 0.56% today, near its consensus price target of $183. The stock shows bullish technical signals with strong moving averages and recent earnings beats in Q2 2026. Revenue growth is steady, with Q3 2026 reaching $5 billion, though margins face pressure from tariffs. The company maintains a Dividend Aristocrat status with consistent payouts.

Outlook is cautiously optimistic with analyst consensus leaning buy, but risks include margin compression and debt levels. The stock offers stability through dividends and sector resilience, yet investors should monitor earnings sustainability and competitive threats in the medical technology space.

Herbalife Nutrition Ltd

HLF trades at $11.71, up 1.65% on the day, with a bearish technical signal from moving averages. The company shows mixed earnings, missing Q2 2026 EPS estimates but achieving four consecutive quarters of sales growth. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24, though negative shareholder equity and high debt levels present financial risks. Recent news includes a planned CFO transition and inclusion in TIME's America's Best Companies 2026 list.

The outlook for HLF balances low valuation against operational and financial challenges. Investment opportunity lies in potential margin improvement and debt reduction, but risks include earnings volatility, high leverage, and competitive pressures in the nutrition space. Analyst sentiment is cautiously optimistic with a majority buy rating.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX

About Herbalife Nutrition Ltd

Herbalife Nutrition Ltd is an international nutrition company.

Read more on HLF